Robert T. Gerlai is a Canadian behaviour geneticist and behavioural neuroscientist.
Robert T. Gerlai | |
---|---|
Born | 1960 (age 63–64) |
Citizenship | Canadian |
Alma mater | Eötvös Loránd University |
Scientific career | |
Fields | Behavior genetics |
Institutions | University of Toronto |
Doctoral advisor | Vilmos Csanyi |
Website | https://www.utm.utoronto.ca/gerlai-lab/home |
Gerlai obtained his PhD in 1987 from the Eötvös Loránd University and the Hungarian Academy of Sciences in Budapest.[citation needed]
Gerlai has worked in the biotechnology (Genentech) and biopharmaceutical research industries (Eli Lilly and Company and Saegis Pharmaceuticals) as Senior Scientist and Vice President of Research, and led pre-clinical as well as clinical research teams developing drugs to treat mild cognitive impairment and Alzheimer's Disease. He also worked at different universities in North America and Europe. He is a Distinguished Professor of behavioral neuroscience at the Department of Psychology at the University of Toronto.[1]
The Web of Science lists over 340 peer-reviewed publications for Gerlai, which have been cited over 17500 times, resulting in an h-index of 68.[2] Gerlai has worked with several different animal species, including paradise fish and mice. He was among the first to use transgenic mice in the analysis of learning and memory[citation needed] and showed that astrocytes play important roles in synaptic plasticity. He is also known for discovering the role of Eph tyrosine kinases and their ephrin ligands in neuronal plasticity.[citation needed] He is considered a leader[citation needed] of zebrafish behavioral neuroscience research, and has been using this species, and studies the effects of alcohol on brain function and behaviour, including social behaviour, fear-anxiety, and learning and memory.[1][3]
Gerlai is an elected Fellow of the International Behavioral Neuroscience Society, of which he also has been president.[4] He is a member of the editorial boards of Biology,[5] Genes, Brain and Behavior,[6] Neurotoxicology and Teratology,[7] Behavioral and Brain Functions,[8] Learning and Behavior,[9] Current Opinion in Behavioral Sciences, Zebrafish, and F1000. He is section editor for behavioral neuroscience of BMC Neuroscience.[10] In 2013, Gerlai received the Distinguished Scientist Award from the International Behavioural and Neural Genetics Society.[11] In 2015, he received the Research Excellence Award from the University of Toronto.[12] In 2019 he received the Outstanding Achievement Award from the International Behavioral Neuroscience Society.[13] In 2019 and again in 2024, he received the 5-year John Carlin Roder Distinguished Professorship in Behavioural Neuroscience at the University of Toronto Mississauga.[14][15] In 2023, he was elected Fellow of the Royal Society of Canada.[citation needed]